Stoke Therapeutics Inc (STOK)

Operating Expenses

$73.62M

Quarterly · Period ending: · USD

STOK logo

STOK Operating Expenses

Latest reported$73.62M
STOK Quarterly Operating Expenses ($1.91M → $73.62M)
High-resolution chart · PNG

STOK operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
73,616,000
58,600,000
61,786,000
52,734,000
41,117,000
47,329,000
36,267,000
34,897,000
33,063,000
31,475,000
31,173,000
29,342,000
29,614,000
28,695,000
29,292,000
29,129,000
27,634,000
27,171,000
24,526,000
22,683,000
22,029,000
16,827,000
14,586,000
13,711,000
13,012,000
11,735,000
11,068,000
9,842,000
8,445,000
6,322,000
4,542,000
3,317,000
3,010,000
1,912,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.